Loading…
Loading…
As of 20 Nov 2026: KMS Medisurgi ₹132.45 (m-cap ₹43.71 Cr) vs Royal Sense ₹65.00 (m-cap ₹35.10 Cr, P/E 5.1). Compare ROE, ROCE, growth, debt, dividends and 1-year returns.
As of · NSE prices; ratios from company filings
| Metric | KMS Medisurgi | Royal Sense |
|---|---|---|
| Share price | ₹132.45 | ₹65.00 |
| Day change | 0.00% | −2.69% |
| Market cap | ₹43.71 Cr | ₹35.10 Cr |
| P/EPrice ÷ trailing 12-month earnings per share; blank for a loss. | — | 5.1 |
| P/BPrice ÷ book value per share. | 5.4 | 0.9 |
| ROEReturn on equity. | 3.1% | 21.0% |
| ROCEReturn on capital employed. | 5.2% | 26.0% |
| Sales growth (3Y CAGR) | 3.5% | — |
| Profit growth (3Y CAGR) | -24.0% | — |
| Debt to equity | 0.09 | 0.32 |
| Dividend yield | 0.04% | 0.00% |
| 1-year price return | — | −70.5% |
| Promoter holding | 74.4% | 62.2% |
| Industry | Medical Equipment & Supplies | Medical Equipment & Supplies |
Open in the compare tool for price charts from one month to five years, scorecards and more companies.
Each line states which company has the higher or lower figure; none of them is a recommendation.
KMS Medisurgi Ltd is larger, with a market cap of ₹43.71 Cr against ₹35.10 Cr for Royal Sense Ltd as of 20 Nov 2026 — about 1.2 times the size.
KMS Medisurgi Ltd has no meaningful P/E right now (a loss over the last twelve months, or no reported earnings), so the two cannot be compared on P/E.
Jivani Markets does not give buy, sell or hold recommendations and is not a SEBI-registered investment adviser or research analyst. The table on this page lays out the facts side by side — price, valuation, returns on capital, growth, debt, dividends and promoter holding — so you can weigh them against your own goals, or with a SEBI-registered adviser.
Prices refresh every few minutes during market hours and ratios update when the companies report results. Each number is the same one shown on the two stock pages.